600645.SS
600645.SS
CNE000000545
VCANBIO CELL & GENE ENG CORP LT
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.454.948.326 1.585.423.174
8.2%
Cost of Revenue 438.799.036 487.742.583
10.0%
Gross Profit 1.016.149.290 1.097.680.592
7.4%
819.600.273 894.109.614
8.3%
Operating Income 196.549.017 203.570.978
3.4%
Pretax Income 174.445.254 135.946.283
28.3%
Net Income Common Stockholders 113.831.246 100.352.111
13.4%
-- --
--
-- --
--
ende